New eye drops pass first safety check in healthy volunteers
NCT ID NCT06352541
First seen Apr 21, 2026 · Last updated May 14, 2026 · Updated 4 times
Summary
This early-stage study tested whether PRO-232 eye drops are safe and tolerable in 28 healthy adults aged 18 to 45. Participants received either the eye drops or a placebo, and researchers monitored for side effects, eye pressure changes, and stinging. Since this was a Phase 1 safety trial in healthy volunteers, there was no treatment for any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigacion e Innovacion en Medicina Traslacional
Mexico City, Mexico
Conditions
Explore the condition pages connected to this study.